OncoPrint mapping of the COMMD10 gene in STAD patients in the TCGA dataset was analyzed using cBioPortal plots (Fig. 1H), which showed less than 3% gene amplification, missense and deep deletion mutations in COMMD10. This evidence concerns the gene COMMD10 and gastric adenocarcinoma.